Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 36)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
24-Nov-09 New Constructs, LLC N/A ENZ: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Reuters Investment Profile N/A Enzo Biochem Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Consulting Industry Market Research and Competitive Analysis 2009 408 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Consulting Industry Trends, Statistics & Analysis 2009 (Summary) 29 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ENZO BIOCHEM INC 5 $25 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ENZO BIOCHEM -- ENZ 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ARQL , CBST , EBS , ENZ , NABI , PDLI -- DRUGS 3 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ENZO BIOCHEM INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
Next 20

Brokerage Reports (Showing 1 to 1 of 1)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
15-Oct-09 Thomson StreetEvents N/A ENZ - Event Transcript of Enzo Biochem conference call, Oct. 15, 2009 / 8:30am ET 15 $75 View Abstract

Independent Reports (Showing 1 to 10 of 35)

Release
Date Contributor Author Title Pages Price More Info
24-Nov-09 New Constructs, LLC N/A ENZ: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Reuters Investment Profile N/A Enzo Biochem Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Consulting Industry Market Research and Competitive Analysis 2009 408 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Consulting Industry Trends, Statistics & Analysis 2009 (Summary) 29 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ENZO BIOCHEM INC 5 $25 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ENZO BIOCHEM -- ENZ 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ARQL , CBST , EBS , ENZ , NABI , PDLI -- DRUGS 3 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ENZO BIOCHEM INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.